AAAAAA

   
Results: 1-13 |
Results: 13

Authors: ANKER GB LONNING PE AAKVAAG A LIEN EA
Citation: Gb. Anker et al., THYROID-FUNCTION IN POSTMENOPAUSAL BREAST-CANCER PATIENTS TREATED WITH TAMOXIFEN, Scandinavian journal of clinical & laboratory investigation, 58(2), 1998, pp. 103-107

Authors: NEDREBO BG ERICSSON UB NYGARD O REFSUM H UELAND PM AAKVAAG A AANDERUD S LIEN EA
Citation: Bg. Nedrebo et al., PLASMA TOTAL HOMOCYSTEINE LEVELS IN HYPERTHYROID AND HYPOTHYROID PATIENTS, Metabolism, clinical and experimental, 47(1), 1998, pp. 89-93

Authors: GEISLER J LIEN EA EKSE D LONNING PE
Citation: J. Geisler et al., INFLUENCE OF AMINOGLUTETHIMIDE ON PLASMA-LEVELS OF ESTRONE SULFATE AND DEHYDROEPIANDROSTERONE-SULFATE IN POSTMENOPAUSAL BREAST-CANCER PATIENTS, Journal of steroid biochemistry and molecular biology, 63(1-3), 1997, pp. 53-58

Authors: LIEN EA ANKER G LONNING PE REFSUM H UELAND PM
Citation: Ea. Lien et al., EFFECTS OF HORMONES ON THE PLASMA-LEVELS OF THE ATHEROGENIC AMINO-ACID HOMOCYSTEINE, Biochemical Society transactions, 25(1), 1997, pp. 33-35

Authors: LONNING PE JOHANNESSEN DC LIEN EA EKSE D FOTSIS T ADLERCREUTZ H
Citation: Pe. Lonning et al., INFLUENCE OF TAMOXIFEN ON SEX-HORMONES, GONADOTROPINS AND SEX-HORMONEBINDING GLOBULIN IN POSTMENOPAUSAL BREAST-CANCER PATIENTS (VOL 52, PG491, 1995), Journal of steroid biochemistry and molecular biology, 57(1-2), 1996, pp. 149-149

Authors: LONNING PE LIEN EA
Citation: Pe. Lonning et Ea. Lien, MECHANISMS OF ACTION OF ENDOCRINE TREATMENT IN BREAST-CANCER, Critical reviews in oncology/hematology, 21(1-3), 1995, pp. 158-193

Authors: LIEN EA ANKER G UELAND PM
Citation: Ea. Lien et al., PHARMACOKINETICS OF TAMOXIFEN IN PREMENOPAUSAL AND POSTMENOPAUSAL WOMEN WITH BREAST-CANCER, Journal of steroid biochemistry and molecular biology, 55(2), 1995, pp. 229-231

Authors: LONNING PE JOHANNESSEN DC LIEN EA EKSE D FOTSIS T ADLERCREUTZ H
Citation: Pe. Lonning et al., INFLUENCE OF TAMOXIFEN ON SEX-HORMONES, GONADOTROPINS AND SEX-HORMONEBINDING GLOBULIN IN POSTMENOPAUSAL BREAST-CANCER PATIENTS, Journal of steroid biochemistry and molecular biology, 52(5), 1995, pp. 491-496

Authors: LONNING PE HELLE SI JOHANNESSEN DC ADLERCREUTZ H LIEN EA TALLY M EKSE D FOTSIS T ANKER GB HALL K
Citation: Pe. Lonning et al., RELATIONS BETWEEN SEX-HORMONES, SEX-HORMONE BINDING GLOBULIN, INSULIN-LIKE GROWTH FACTOR-L AND INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-1IN POSTMENOPAUSAL BREAST-CANCER PATIENTS, Clinical endocrinology, 42(1), 1995, pp. 23-30

Authors: LIEN EA ANKER G LONNING PE UELAND PM
Citation: Ea. Lien et al., DETERMINATION OF DROLOXIFENE AND 2 METABOLITES IN SERUM BY HIGH-PRESSURE LIQUID-CHROMATOGRAPHY, Therapeutic drug monitoring, 17(3), 1995, pp. 259-265

Authors: ANKER G LONNING PE UELAND PM REFSUM H LIEN EA
Citation: G. Anker et al., PLASMA-LEVELS OF THE ATHEROGENIC AMINO-ACID HOMOCYSTEINE IN POSTMENOPAUSAL WOMEN WITH BREAST-CANCER TREATED WITH TAMOXIFEN, International journal of cancer, 60(3), 1995, pp. 365-368

Authors: MILLWARD MJ LIEN EA ROBINSON A CANTWELL BMJ
Citation: Mj. Millward et al., HIGH-DOSE (480 MG DAY) TAMOXIFEN WITH ETOPOSIDE - A STUDY OF A POTENTIAL MULTIDRUG-RESISTANCE MODULATOR/, Oncology, 51(1), 1994, pp. 79-83

Authors: LONNING PE LIEN EA
Citation: Pe. Lonning et Ea. Lien, PHARMACOKINETICS OF ANTI-ENDOCRINE AGENTS, Cancer surveys, 17, 1993, pp. 343-370
Risultati: 1-13 |